SCHEMBL7988288

SCHEMBL7988288

CCOC(=O)C(=NO)C(=O)c1cccc(OC)c1

nearest known ligand 0.58

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CES2 O00748 1/20 0.58
CES1 P23141 1/20 0.58
PARP1 P09874 1/20 0.48
ALDH1A1 P00352 3/20 0.46
TSHR P16473 3/20 0.46
MAPK1 P28482 2/20 0.46
TDP1 Q9NUW8 1/20 0.46
L3MBTL1 Q9Y468 1/20 0.46
NPC1 O15118 7/20 0.46
RAB9A P51151 6/20 0.46
MAPT P10636 3/20 0.46
NPSR1 Q6W5P4 2/20 0.46
LMNA P02545 1/20 0.46
PPARG P37231 1/20 0.46
NCOA2 Q15596 1/20 0.46
NCOA1 Q15788 1/20 0.46
NCOA3 Q9Y6Q9 1/20 0.46
MEN1 O00255 4/20 0.46
KMT2A Q03164 4/20 0.46
SMN1; SMN2 Q16637 3/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7988285 1.00 CES2 (0.58) CES2CES1PARP1ALDH1A1TSHR
SCHEMBL2007841 0.86 CES2 (0.69) CES2CES1PARP1ALDH1A1TSHR
SCHEMBL7988180 0.83 CES2 (0.53) CES2CES1ALDH1A1MAPTSMN1; SMN2
SCHEMBL7988181 0.83 CES2 (0.53) CES2CES1ALDH1A1MAPTSMN1; SMN2
SCHEMBL1339638 0.82 CES2 (0.51) CES2CES1PARP1ALDH1A1TSHR
SCHEMBL29697823 0.82 CES2 (0.51) CES2CES1PARP1ALDH1A1TSHR
SCHEMBL1339641 0.82 CES2 (0.51) CES2CES1PARP1ALDH1A1TSHR
SCHEMBL19663921 0.81 ALDH1A1 (0.61) CES2CES1ALDH1A1TSHRNPC1
SCHEMBL1968821 0.81 ALDH1A1 (0.61) CES2CES1ALDH1A1TSHRNPC1
SCHEMBL1126729 0.81 ALDH1A1 (0.61) CES2CES1ALDH1A1TSHRNPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6288061-B1 INTERLEUKIN INHIBITORS; ASTHMA, BRONCHODILATOR AGENTS, ANTIALLERGENS WELFIDE CORPORATION (JP) 2001-09-11 US disclosed